The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
- 20 March 2018
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 135 (6) , 923-938
Abstract
Glioblastoma is the most frequent malignant primary brain tumor. In a hierarchical tumor model, glioblastoma stem-like cells (GSC) play a major role in tumor initiation and maintenance as well as in therapy resistance and recurrence. Thus, targeting this cellular subset may be key to effective immunotherapy. Here, we present a mass spectrometry-based analysis of HLA-presented peptidomes of GSC and glioblastoma patient specimens. Based on the analysis of patient samples (n = 9) and GSC (n = 3), we performed comparative HLA peptidome profiling against a dataset of normal human tissues. Using this immunopeptidome-centric approach we could clearly delineate a subset of naturally presented, GSC-associated HLA ligands, which might serve as highly specific targets for T cell-based immunotherapy. In total, we identified 17 antigens represented by 41 different HLA ligands showing natural and exclusive presentation both on GSC and patient samples. Importantly, in vitro immunogenicity and antigen-specific target cell killing assays suggest these peptides to be epitopes of functional CD8+ T cell responses, thus rendering them prime candidates for antigen-specific immunotherapy of glioblastoma.Keywords
Funding Information
- Filling-The-Gap program
- Hartmann Müller-Stiftung für Medizinische Forschung
- EMDO Stiftung
- HSM-2
- ERC grant MUTAEDITING (339842)
This publication has 40 references indexed in Scilit:
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaJournal of Clinical Oncology, 2013
- Signatures of mutational processes in human cancerNature, 2013
- Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancerCancer Immunology, Immunotherapy, 2013
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene functionNucleic Acids Research, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagramsBMC Genomics, 2008